Brookfield Office Acquires Assets - Analyst Blog
June 11 2012 - 12:26PM
Zacks
Brookfield Office Properties Inc. (BPO), a real
estate investment trust (REIT), has recently announced the
acquisition of two office towers named Metropolitan Park East &
West, in the Seattle central business district. Brookfield shelled
out $210 million to acquire the 700,000 square-foot Class A office
campus, of which $126 million came from the earlier obtained
financing facility and the balance from its own cash reserves.
The two Metropolitan Park towers are 20 and 18 stories,
respectively, and have a parking space for 867 cars. The towers are
combined 85% leased and enjoy an excellent location advantage
adjacent to Interstate 5 and the South Lake Union submarket.
This acquisition is beneficial to Brookfield as the Metropolitan
towers are located in the strong Seattle market, which is home to a
large number of technology and science companies with a highly
skilled work force. The acquisition is also in line with
Brookfield's policy of owning premium properties in top urban
markets with tenant diversification in the technology and social
media sector.
Based in New York, Brookfield owns, develops and manages premier
office properties in the United States, Canada and Australia. It
also provides ancillary real estate service businesses, such as
tenant service and amenities.
The company invests in high growth and high-barrier-to-entry
markets, with its main focus on the creation and sustainability of
growing streams of cash flow.
Brookfield currently retains a Zacks #3 Rank, which translates
into a short-term Hold rating. We also have a long-term Neutral
recommendation on the stock. One of its competitors, Core
Site Realty Corporation (COR) holds a Zacks #2 Rank which
translates into a short-term Buy rating.
BROOKFLD OFFICE (BPO): Free Stock Analysis Report
CORESITE REALTY (COR): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Cortex Pharm (AMEX:COR)
Historical Stock Chart
From Nov 2024 to Dec 2024
Cortex Pharm (AMEX:COR)
Historical Stock Chart
From Dec 2023 to Dec 2024
Real-Time news about Cortex Pharmaceuticals, (American Stock Exchange): 0 recent articles
More Cortex Pharm News Articles